📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: DNage

1.1 - Company Overview

DNage Logo

DNage

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of life sciences research and development focused on discovering and developing products for aging diseases caused by DNA damage.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to DNage

Cancer Prevention Pharmaceuticals Logo

Cancer Prevention Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceutical agents and prevention therapies for people at elevated risk of cancer in the United States. Offers difluoro-methyl ornithine for clinical cancer prevention and treatment trials and develops diagnostic methods.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cancer Prevention Pharmaceuticals company profile →
Applied Genetic Technologies Logo

Applied Genetic Technologies

HQ: United States Website
  • Description: Provider of AAV-based gene therapies, conducting human clinical trials for rare diseases. Offerings include AGTC-501, a Phase 2/3 gene therapy for X-Linked Retinitis Pigmentosa delivering full-length RPGR, preclinical AAV programs for dry age-related macular degeneration and cone rod dystrophy, and the VISTA Phase 2/3 trial evaluating AGTC-501.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Applied Genetic Technologies company profile →
Evox Therapeutics Logo

Evox Therapeutics

HQ: United Kingdom Website
  • Description: Provider of engineered exosome-based delivery and therapeutics via its DeliverEX platform to modify exosomes, load drugs, and target delivery to specific organs. Solutions include treatments for rare diseases, exosome-enabled gene therapy (AAV cloaking), gene editing with CRISPR, RNA therapeutics, and precision targeting to the brain and central nervous system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Evox Therapeutics company profile →
Som Pharmaceuticals Logo

Som Pharmaceuticals

HQ: Switzerland Website
  • Description: Provider of novel anti-tumour somatostatin analogue (SSA) peptide medicines and diagnostics for patients with rare diseases that have unmet medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Som Pharmaceuticals company profile →
Primrose Therapeutics Logo

Primrose Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on creating treatments for polycystic kidney disease (PKD), a life-threatening genetic disorder affecting 600,000 Americans and 12.5 million people worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Primrose Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for DNage

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to DNage

2.2 - Growth funds investing in similar companies to DNage

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for DNage

4.2 - Public trading comparable groups for DNage

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to DNage

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About DNage

What does DNage do?

DNage is a provider of life sciences research and development focused on discovering and developing products for aging diseases caused by DNA damage.

Who are DNage's competitors?

DNage's competitors and similar companies include Cancer Prevention Pharmaceuticals, Applied Genetic Technologies, Evox Therapeutics, Som Pharmaceuticals, and Primrose Therapeutics.

Where is DNage headquartered?

DNage is headquartered in The Netherlands.

How many employees does DNage have?

DNage has 1,000 employees 🔒.

When was DNage founded?

DNage was founded in 2010 🔒.

What sector and industry vertical is DNage in?

DNage is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for DNage

Who are the top strategic acquirers in DNage's sector and industry

Top strategic M&A buyers and acquirers in DNage's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for DNage?

Top strategic M&A buyers groups and sectors for DNage include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in DNage's sector and industry vertical

Which are the top PE firms investing in DNage's sector and industry vertical?

Top PE firms investing in DNage's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in DNage's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in DNage's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in DNage's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to DNage include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in DNage's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for DNage?

The key public trading comparables and valuation benchmarks for DNage include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for DNage for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for DNage with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in DNage's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for DNage with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in DNage's' sector and industry vertical?

Access recent funding rounds and capital raises in DNage's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for DNage